Canthera Discovery is an oncology-focused small molecule drug discovery and development organisation, bringing together leading researchers and organisations from industry and academia to find cures for cancer.
Canthera Discovery is a highly successful cancer research organisation that evolved from the Cancer Therapeutics CRC which was founded in 2007.
Our research and development platform spans the full range of technologies required to discover small molecules and develop them to clinical candidates.
Our continuous pipeline of projects draws on our expansive suite of biotech capabilities and expertise to advance promising early drug discoveries.
We welcome new partners – both from industry and research – to join our world-class collaboration. Together, we can help advance your project.
Every new cancer drug starts with a great idea.
Canthera Discovery is converting these ideas into potential new medicines by ensuring that Australian research is translated into therapeutic outcomes for patients.
It is with a deep sense of sadness and loss that we report the sudden and untimely passing of Canthera Discovery Chair, Dr Peter Woodgate, over the Christmas period. The staff and Board of Directors...
A drug discovered by Cancer Therapeutics CRC scientists has entered Phase 2 clinical trials. Amplia Therapeutics Limited recently announced the recruitment of the first patient to the AC...